论文部分内容阅读
西安杨森成立于1985年,是由美国强生所属比利时杨森制药有限公司与陕西省医药总公司、陕西省汉江药业股份有限公司、中国医药工业公司和中国医药对外贸易总公司合资兴建的大型现代化制药企业,按当时的汇率,总投资额为3500万美元。成立16年间,西安杨森不断发展壮大,双方股东增加了注册资本1.4亿元人民币,坚定
Established in 1985, Xian Janssen is a large-scale, modern pharmaceutical company jointly established by the American Johnson & Johnson Belgium Janssen Pharmaceutical Co., Ltd. and Shaanxi Provincial Pharmaceutical Corporation, Shaanxi Hanjiang Pharmaceutical Co., Ltd., China National Pharmaceutical Industry Corporation and China National Pharmaceutical Foreign Trade Corporation. According to the exchange rate at that time, the company had a total investment of 35 million U.S. dollars. In the 16 years since its establishment, Xi’an Janssen has continued to grow and develop. Both shareholders have increased their registered capital by RMB 140 million.